OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Pathology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors	159
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment	86
SMARCA4‐deficient rhabdoid tumours show intermediate molecular features between SMARCB1‐deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type	80
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance	77
Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats	76
Modelling hereditary diffuse gastric cancer initiation using transgenic mouse‐derived gastric organoids and single‐cell sequencing	73
Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids	67
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities	63
Spatial profiling of ANO7 in prostate tissue: links to AR‐signalling‐associated lipid metabolism and inflammation	59
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy	54
Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer^†	52
Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells	51
The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients	50
Presence of Tim3⁺ and PD‐1⁺CD8⁺T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and di	48
Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma	47
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer	46
Issue Information	46
Artificial intelligence to identify genetic alterations in conventional histopathology	43
Escape from senescence: molecular basis and therapeutic ramifications	41
Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma	40
Pseudobudding: ruptured glands do not represent true tumor buds	39
Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer	39
CRISPR–Cas9 screening identifies the role of FER as a tumor suppressor	38
In high‐grade ovarian carcinoma, platinum‐sensitive tumor recurrence and acquired‐resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and	38
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer	37

Field cancerization in breast cancer	37
Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells	37
Integrating computational pathology and proteomics to address tumor heterogeneity	33
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response	33
Silencing GRHL3 promotes multiple organ distant metastasis of lung squamous cell carcinoma cells by enhancing SOX2 stability via SIRT1	31
	30
	30